-
Mashup Score: 0Hypertrophic Cardiomyopathy Association has helped advance HCM care - 9 month(s) ago
The Hypertrophic Cardiomyopathy Association (HCMA) has helped guide and advance HCM care not only for patients, but also for hospitals and physicians.
Source: cardiovascularbusiness.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 9When to Order an Echocardiogram to Evaluate for HCM - 9 month(s) ago
View our full Microlesson Series on HCM Playlist: bit.ly/3KEyrKGThe American Society of Echocardiography offers in-depth education on cardiovascular ultrasou…
Source: www.youtube.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
#DidYouKnow we have an entire Microlesson Series on HCM, comprised of 13 videos (and counting) that dive into all things #HCM? View them all on our YouTube channel: https://t.co/ao4TNZv2CN https://t.co/Josuk45jKt
-
-
Mashup Score: 1Exercise plays a key part in HCM management - 9 month(s) ago
Matthew Martinez, MD, detailed the many ways HCM care management is changing during an exclusive interview at ASE 2023.
Source: cardiovascularbusiness.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Video - Matthew Martinez, MD, Atlantic Health System Sports Cardiology, explains how HCM care management is changing #cardiotwitter @mmartinezheart @morristownheart @AtlanticHealth #HCM #sportscardiology @ASE360 https://t.co/TCRz9vID1y
-
-
Mashup Score: 8HCM Microlesson Case Example 6: What Causes Systolic Anterior Motion of the Mitral Valve? - 9 month(s) ago
View our full Microlesson Series on HCM Playlist: bit.ly/3KEyrKGThe American Society of Echocardiography offers in-depth education on cardiovascular ultrasou…
Source: www.youtube.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
What causes systolic anterior motion of the mitral valve? 🫀 Check out the newest video from our Microlesson Series on Hypertrophic Cardiomyopathy (#HCM)! https://t.co/XsmCYyCO0Y https://t.co/HdZPHlXXhl
-
-
Mashup Score: 7Aficamten for Drug-Refractory Severe Obstructive Hypertrophic Cardiomyopathy in Patients Receiving Disopyramide: REDWOOD-HCM Cohort 3 - 10 month(s) ago
How this work applies to patients
Source: www.onlinejcf.comCategories: Cardiologists, Latest HeadlinesTweet-
Aficamten on top of disopyramide and AVN blocker - REDWOOD-HCM Cohort 3 manuscript is now out in @JCardFail Aficamten was safe (3 neg intropes), no interaction with disopyramide, and effective in reducing LVOTO (figures) Link: https://t.co/B2qR4UZgxN #CardioTwitter #HCM https://t.co/wI3G73VZUz
-
-
Mashup Score: 2
Did you know that hypertrophic cardiomyopathy (HCM) is estimated to affect 20 million people worldwide? Learn more about novel targeted agents for this condition from our expert panel.
Source: www.medscape.orgCategories: Cardiology News and Journals, Latest HeadlinesTweet-
➡️ Did you know that hypertrophic cardiomyopathy is estimated to affect 20 million people worldwide? Learn more about novel targeted agents for this condition from our expert panel. #HCM #MedEd #CME #CardioTwitter 📝 https://t.co/rnLjX2RwiW https://t.co/X0AoOCNbWH
-
-
Mashup Score: 5
AbstractAims. Hypertrophic cardiomyopathy (HCM) is characterized by phenotypic heterogeneity that is partly explained by the diversity of genetic variants contr
Source: OUP AcademicCategories: Cardiologists, Latest HeadlinesTweet-
🫀The #genetic architecture of #Hypertrophic #cardiomyopathy #HCM in #Egyptian pts: 🧬Minor #Genes could be more relevant than in other populations Congratulations @aguib_y & coll. More 👉https://t.co/1kD2wG2ste @ehj_ed @ESC_Journals @rladeiraslopes @DrMagdiYacoub @ShehabAnwer https://t.co/o0LzAP4lyP
-
-
Mashup Score: 0
Did you know that hypertrophic cardiomyopathy (HCM) is estimated to affect 20 million people worldwide? Learn more about novel targeted agents for this condition from our expert panel.
Source: MedscapeCategories: Cardiology News and Journals, Latest HeadlinesTweet-
➡️ Did you know that hypertrophic cardiomyopathy is estimated to affect 20 million people worldwide? Learn more about novel targeted agents for this condition from our expert panel. #HCM #MedEd #CME #CardioTwitter 📝 https://t.co/YMUP9oB5v9 https://t.co/l1slamGNP6
-
-
Mashup Score: 8What’s the Difference Between Dynamic and Fixed Obstruction? - 10 month(s) ago
View our full Microlesson Series on HCM Playlist: bit.ly/3KEyrKGThe American Society of Echocardiography offers in-depth education on cardiovascular ultrasou…
Source: YouTubeCategories: Cardiology News and Journals, Latest HeadlinesTweet-
What’s the difference between dynamic and fixed obstruction? 🫀 Check out the newest video from our Microlesson Series on Hypertrophic Cardiomyopathy (#HCM)! https://t.co/jkwop40lQr https://t.co/JWLoU40sbS
-
-
Mashup Score: 0
Ted Abraham, MD, explained why HCM has entered the limelight at recent cardiology conferences, including ASE 2023.
Source: Cardiovascular BusinessCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Video of Ted Abraham, MD, UCSF, explaining why HCM has come into the limelight at cardiology conferences, most notably at #ASE2023. #Cardiotwitter #HCM @ASE360 #echofirst #Mavacamten https://t.co/fECPSKTmAJ
-
Lisa Salberg, founder and CEO of the Hypertrophic Cardiomyopathy Association, was diagnosed with HCM in elementary school and told it could be fatal, so she asked the doctor if needed to bother finishing her homework anymore. @ASE360 #HCM #ASE2023 https://t.co/dSAYVg71P4